Corrigendum to: Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency

J Infect Dis. 2020 Feb 18;221(5):854. doi: 10.1093/infdis/jiz530.

Walter R J Taylor^{1

2

3}, Sim Kheng¹, Sinoun Muth¹, Pety Tor⁴, Saorin Kim⁴, Steven Bjorge⁵, Narann Topps⁵, Khem Kosal⁶, Khon Sothea⁶, Phum Souy⁷, Chuor Meng Char¹, Chan Vanna⁸, Po Ly¹, Virak Khieu¹, Eva Christophel⁹, Alexandra Kerleguer⁴, Antonella Pantaleo¹⁰, Mavuto Mukaka^{3

11}, Didier Menard^{4

12}, J Kevin Baird^{11

13}

¹ National Center for Parasitology, Entomology, and Malaria Control, Phnom Penh.
² Service de Médecine Tropicale et Humanitaire, Hôpitaux Universitaires de Genève, Switzerland.
³ Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand.
⁴ Institut Pasteur du Cambodge, Phnom Penh.
⁵ World Health Organization (WHO) Cambodia Country Office, Phnom Penh.
⁶ Pailin Referral Hospital, Pailin.
⁷ Anlong Veng Referral Hospital, Anlong Venh.
⁸ Pramoy Health Center, Veal Veng, Cambodia.
⁹ WHO Western Pacific Regional Office, Manila, the Philippines.
¹⁰ Department of Biomedical Science, University of Sassari, Italy.
¹¹ Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, United Kingdom.
¹² Malaria Genetics and Resistance Group, Biology of Host-Parasite Interactions Unit, Institut Pasteur, Paris, France.
¹³ Eijkman Oxford Clinical Research Unit, Eijkman Institute of Molecular Biology, Jakarta, Indonesia.

No abstract available

Publication types